A. N. YAVUZ Et Al. , "Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in streptozotocin induced sporadic alzheimer’xxs rat model," 31. ECNP Congress , BARSELONA, Spain, 2018
YAVUZ, A. N. Et Al. 2018. Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in streptozotocin induced sporadic alzheimer’xxs rat model. 31. ECNP Congress , (BARSELONA, Spain).
YAVUZ, A. N., YILDIZ, S., KELEŞ, R. M., ÇAM, M. E., & KABASAKAL, L., (2018). Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in streptozotocin induced sporadic alzheimer’xxs rat model . 31. ECNP Congress, BARSELONA, Spain
YAVUZ, AYŞE Et Al. "Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in streptozotocin induced sporadic alzheimer’xxs rat model," 31. ECNP Congress, BARSELONA, Spain, 2018
YAVUZ, AYŞE N. Et Al. "Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in streptozotocin induced sporadic alzheimer’xxs rat model." 31. ECNP Congress , BARSELONA, Spain, 2018
YAVUZ, A. N. Et Al. (2018) . "Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in streptozotocin induced sporadic alzheimer’xxs rat model." 31. ECNP Congress , BARSELONA, Spain.
@conferencepaper{conferencepaper, author={AYŞE NUR YAVUZ Et Al. }, title={Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in streptozotocin induced sporadic alzheimer’xxs rat model}, congress name={31. ECNP Congress}, city={BARSELONA}, country={Spain}, year={2018}}